CorMedix Inc. — Director's Dealing 2012

Nov 15, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2012-11-13

Reporting Person: Duffy Matthew (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-11-13	Senior Convertible Note (convertible into common stock)	$0.35	P	0	Acquired	2013-11-13	Common Stock, $0.001 par value per share (28571)	Direct
2012-11-13	Warrant (right to purchase common stock)	$0.40	P	0	Acquired	2017-11-13	Common Stock, $0.001 par value per share (25000)	Direct

Footnotes

F1: On November 13, 2012, the reporting person acquired in a private placement $10,000 of (i) 9% Senior Convertible Notes, convertible into shares of the Company's common stock at a conversion price of $0.35 per share; and (ii) a five-year redeemable warrant to purchase common stock at an exercise price of $0.40 per share.